Adrenomed

Hennigsdorf, Germany · Founded 2009 · Privately Held (backing)

Developer of clinical-stage pharmaceutical products designed to improve vascular integrity. Adrenomed is based in Hennigsdorf, Germany and was founded in 2009. Its last reported valuation was $134 million in Mar 2021. It has raised $61.3 million.

Last reported valuation
$133.9M
Oct 2026
Priced at
—
Total raised
$61.3M
Last round
—

Who backs Adrenomed?

10 investors
InvestorType
VU Venture PartnersOther
Brandenburg KapitalVenture capital
HBM PartnersVenture capital
Wellington PartnersVenture capital
KfW GroupOther
Deutsche Biotech Innovativ—
ExpoCapital GmbH—
HBM Healthcare Investments—
HINKEL & Cie—
Investitionsbank des Landes Brandenburg—
The directory is free. Investor activity — the working column — is Pro.Unlock prospecting columns

Membership and data by Private Market View

Adrenomed investors

10 investors are on record for Adrenomed, including VU Venture Partners, Brandenburg Kapital, HBM Partners and Wellington Partners.

Free account
More of Adrenomed with a free account
  • ·Watch Adrenomed: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

For fundraisers
Work this list, don’t just read it

These 10 firms already write checks for companies like Adrenomed. Build the wider list: every firm that has backed a company like this one, ranked by how often and how recently.

Find investors like these →

Membership and data by Private Market View